Acumen Pharmaceuticals Inc

NASDAQ:ABOS  
16.23
+0.05 (+0.31%)
Earnings Announcements

Acumen Says Cash, Cash Equivalents And Marketable Securities Were $68.8 Million As Of June 30, 2021

Published: 08/16/2021 21:14 GMT
Acumen Pharmaceuticals Inc (ABOS) - Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2021 and Business Highlights.
Acumen Pharmaceuticals Inc - Cash, Cash Equivalents and Marketable Securities Were $68.8 Million As of June 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.23

More details on our Analysts Page.